Clinical Research Directory
Browse clinical research sites, groups, and studies.
Validation of TAD in HER-2 with More Than 2 Lymph Nodes
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia
Summary
The main objective of the study is to validate the DAT technique in patients with Her2-positive breast cancer who have more than two positive axillary lymph nodes at diagnosis. After receiving adequate oncological treatment and axillary assessment by ultrasound for complete radiological response, DAT and Berg level I and II lymphadenectomy will be performed to assess false negatives and positives, as well as their sensitivity and specificity.
Official title: It is Possible to Reduce the Performance of Axillary Lymphadenectomies in Patients with HER2-positive Breast Cancer with a Clinically Positive Axilla At Diagnosis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
21
Start Date
2024-06-30
Completion Date
2026-02
Last Updated
2025-02-12
Healthy Volunteers
No
Interventions
Targeted axillary dissection and subsequently a lymphadenectomy
Selective sentinel lymph node biopsy is performed, along with biopsy of the node marked at diagnosis. Subsequently, a lymphadenectomy is performed, with the three samples separated for pathological study during the same surgical procedure
Locations (1)
Hospital Clínico de la Comunidad Valenciana
Valencia, Valencia, Spain